Annual report pursuant to Section 13 and 15(d)

Note 10 - Investment in Macrophage Therapeutics, Inc. (Details Textual)

v3.8.0.1
Note 10 - Investment in Macrophage Therapeutics, Inc. (Details Textual) - USD ($)
 1 Months Ended 12 Months Ended
Mar. 11, 2015
Jan. 31, 2017
Jul. 31, 2016
May 31, 2016
Dec. 31, 2015
Mar. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Preferred Stock, Shares Authorized             5,000,000 5,000,000  
Preferred Stock, Par or Stated Value Per Share             $ 0.001 $ 0.001  
Preferred Stock, Shares Issued             0 0  
Derivative Liability             $ 63,000 $ 63,000  
Preferred Stock Dividends and Other Adjustments             $ 46,000
Preferred Convertible Stock, Right to Exchange for Common Shares, Minimum Required Proceeds from Initial Public Offering                 $ 50,000,000
Weighted Average Price Common Stock Percentage                 80.00%
Future Common Stock Conversion Share Price         3.00%       3.00%
Reclassification of Funds Invested   $ 200,000         200,000    
Common Stock [Member]                  
Reclassification of Funds Invested                
Dr. Michael Goldberg [Member]                  
Convertible Preferred Stock, Percent of Shares Reserved           40.00%      
Dr. Michael Goldberg [Member] | MT [Member]                  
Payments to Acquire Businesses and Interest in Affiliates     $ 200,000            
Macrophage Therapeutics [Member]                  
Common Stock Shares Authorized Upon Exercise of Warrants           1,500      
Convertible Preferred Stock Shares Issued Upon Conversion, Per Unit           1      
Common Stock Warrants, Issued Upon Conversion, Per Unit           30      
Macrophage Therapeutics [Member] | Common Stock [Member]                  
Common Stock as Percentage of Common Equity           1.00%      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 300           300    
Platinum [Member] | MT [Member]                  
Payments to Acquire Businesses and Interest in Affiliates     $ 300,000 $ 200,000 $ 200,000        
MT [Member]                  
Convertible Preferred Stock, PIK Coupon, Percentage     10.00%            
Convertible Preferred Stock, Conversion Price, Market Cap     $ 500,000,000            
Convertible Preferred Stock [Member]                  
Preferred Stock, Shares Authorized           50      
Preferred Stock, Par or Stated Value Per Share           $ 50,000      
Convertible Preferred Stock [Member] | Macrophage Therapeutics [Member]                  
Preferred Stock Dividends and Other Adjustments           $ 46,000      
Cumulative Preferred Stock [Member]                  
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants $ 500,000                
Issuance of Stock and Warrants for Purchase Agreement, Remaining Amount                 $ 2,000,000
Preferred Stock, Fair Value Put Option                 113,000
Future Common Stock Conversion Denominator, Value         $ 50,000       50,000
Cumulative Preferred Stock [Member] | Macrophage Therapeutics [Member]                  
Preferred Stock, Shares Authorized           50      
Preferred Stock, Shares Issued           10      
Preferred Stock Dividends and Other Adjustments                 $ 46,000
Preferred Stock, Redemption Price Per Share         $ 58,320       $ 58,320